Aytu Biopharma, Inc., a Colorado-based specialty pharmaceutical company, is making waves in the world of therapeutics and consumer healthcare products. The company is dedicated to developing and commercializing novel treatments and products, both in the United States and worldwide. Among Aytu's offerings are Adzenys XR-ODT and Cotempla XR-ODT, novel treatments for attention deficit hyperactivity disorder (ADHD) that are approved for use in patients six years and older. Additionally, the company provides Karbinal ER for the treatment of allergies, and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children with fluoride deficiency. Previously known as Aytu BioScience, Inc., the company changed its name to Aytu Biopharma, Inc. in March 2021. Founded in 2015, Aytu is positioning itself as a major player in the world of specialty pharmaceuticals.
Aytu Biopharma's ticker is AYTU
The company's shares trade on the NASDAQ stock exchange
They are based in Englewood, Colorado
There are 51-200 employees working at Aytu Biopharma
It is aytubio.com
Aytu Biopharma is in the Healthcare sector
Aytu Biopharma is in the Biotechnology industry
The following five companies are Aytu Biopharma's industry peers: